ReviewBioengineering (Basel, Switzerland)2025
Generative Adversarial Networks in Dermatology: A Narrative Review of Current Applications, Challenges, and Future Perspectives.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sustaining High Reliability Amid Artificial Intelligence Adoption in Oncology.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026Article
- Automated Skin Lesion and Cancer Detection Using Computer Vision: A Comprehensive Review.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generative Adversarial Networks (GANs) have emerged as powerful tools in artificial intelligence (AI) with growing relevance in medical imaging. In dermatology, GANs are revolutionizing image analysis, enabling synthetic image generation, data augmentation, color standardization, and improved diagnostic model training. This narrative review explores the landscape of GAN applications in dermatology, systematically analyzing 27 key studies and identifying 11 main clinical use cases. These range from the synthesis of under-represented skin phenotypes to segmentation, denoising, and super-resolution imaging. The review also examines the commercial implementations of GAN-based solutions relevant to practicing dermatologists. We present a comparative summary of GAN architectures, including DCGAN, cGAN, StyleGAN, CycleGAN, and advanced hybrids. We analyze technical metrics used to evaluate performance-such as Fréchet Inception Distance (FID), SSIM, Inception Score, and Dice Coefficient-and discuss challenges like data imbalance, overfitting, and the lack of clinical validation. Additionally, we review ethical concerns and regulatory limitations. Our findings highlight the transformative potential of GANs in dermatology while emphasizing the need for standardized protocols and rigorous validation. While early results are promising, few models have yet reached real-world clinical integration. The democratization of AI tools and open-access datasets are pivotal to ensure equitable dermatologic care across diverse populations. This review serves as a comprehensive resource for dermatologists, researchers, and developers interested in applying GANs in dermatological practice and research. Future directions include multimodal integration, clinical trials, and explainable GANs to facilitate adoption in daily clinical workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.